phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Experimental Neoplasms

phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Halmos, G; Nagy, A; Plonowski, A; Schally, AV; Sun, B	1

Other Studies

1 other study(ies) available for phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and Experimental Neoplasms

Article	Year
Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238. International journal of oncology, 2002, Volume: 20, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cytotoxins; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Octreotide; Prostatic Neoplasms; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured	2002

Article

Year

Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.

International journal of oncology, 2002, Volume: 20, Issue:2

Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cytotoxins; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Octreotide; Prostatic Neoplasms; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured

2002